BCSS
Bain Capital Gss Inv- A
NYSE · N/A
$10.16
+0.00 (+0.00%)
Open$10.20
Previous Close$10.16
Day High$10.20
Day Low$10.16
52W High$10.21
52W Low$9.95
Volume—
Avg Volume49.7K
Market Cap593.34M
P/E Ratio—
EPS—
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 111.35M | 100.51M | 95.09M |
| Net Income | 16.67M | 13.47M | 16.69M |
| Profit Margin | 15.0% | 13.4% | 17.6% |
| EBITDA | 31.80M | 24.81M | 26.28M |
| Free Cash Flow | 15.88M | 18.55M | 20.53M |
| Rev Growth | +5.4% | +14.2% | +20.0% |
| Debt/Equity | 0.47 | 0.39 | 0.42 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.13 | +4.25% | — | 3.64B |
| PICS | Pics Nv | $15.73 | +4.73% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.99 | -0.20% | — | 655.09M |
| CCCX | Churchill Capital Corp X-A | $11.66 | +8.57% | — | 606.90M |
| BEAG | Bold Eagle Acquisition Cor-A | $10.53 | +0.10% | 63.0 | 605.14M |
| CEPF | Cantor Equity Partners-Cl A | $10.46 | +0.48% | 364.8 | 597.79M |